PROGRAM EVALUATION

Please provide the following information:

FIRST NAME

LAST NAME

PROFESSION

SPECIALTY

COUNTRY

E-MAIL



Question 1: Please rate the presentations according to the following scale by choosing the appropriate numbers in the table below.

MASLD: Understanding the Magnitude of the Problem and Role of the Clinician
Zobair Younossi, MD, MPH

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



Effective Tools in Properly Diagnosing MASLD/MASH
Alina Allen, MD

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



State of the Art Management of MASLD/MASH
Kenneth Cusi, MD, FACP, FACE

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



Question & Answer Session
All faculty

Was the topic selected appropriate for the audience?
Relevance to My Practice
Balanced and Without Commercial Interest
Was the presentation clear, organized and understandable?



Question 2: Please indicate how well you think the learning objectives were covered according to the following scale by choosing the appropriate numbers in the table below.

Learning Objective 1
Increase awareness about MASLD, as it carries a significant morbidity and mortality risk

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Learning Objective 2
Understand the appropriate treatment protocols to follow once MASLD has been determined, and when to refer to a specialist

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Learning Objective 3
Apply the latest practices for the effective treatment of MASLD as indicated in the guidelines adopted by most associations, including AASLD and AACE

Objective Was Met
Confidence in Personal Ability to Achieve the Objective BEFORE the Presentations
Confidence in Personal Ability to Achieve the Objective AFTER the Presentations



Question 3: Did this program increase or expand your knowledge of the topics presented by the speakers?



Question 4: Based on the information presented, do you intend to apply the knowledge gained to your clinical practice?

Please explain your answer.

Question 5: Please include any other comments you may have, including suggestions for future programs.






This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Novo Nordisk A/S.



A Worldwide Initiative for Diabetes Education for Health Care Professionals